REQUEST A DEMO
Total
USD $0.00
Search more companies

Mundipharma (Thailand) Limited (Thailand)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Mundipharma (Thailand) Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mundipharma (Thailand) Limited is a company in Thailand, with a head office in Bangkok , Special Governed District of. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on June 01, 2026. It currently has a total number of 16 (estimated) employees. There was a net sales revenue drop of 48.97% reported in Mundipharma (Thailand) Limited’s latest financial highlights for 2024. Its total assets grew by 8.39% over the same period. The net profit margin of Mundipharma (Thailand) Limited increased by 21.63% in 2024.

Headquarters
127 Ratchadamri Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10330

Contact Details: Purchase the Mundipharma (Thailand) Limited report to view the information.

Basic Information
Total Employees:
Purchase the Mundipharma (Thailand) Limited report to view the information.
Financial Auditors:
Purchase the Mundipharma (Thailand) Limited report to view the information.
Incorporation Date:
June 01, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Mundipharma (Thailand) Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
-48.97%
Total Operating Revenue
-48.23%
Operating Profit
440.99%
EBITDA
440.99%
Net Profit/Loss for the Period
384.27%
Total Assets
8.39%
Total Equity
17.86%
Operating Profit Margin
27.26%
Net Profit Margin
21.63%
Return on Equity (ROE)
11.47%
Quick Ratio
-0.03%
Cash Ratio
0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?